These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38719893)

  • 1. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma.
    Ozaki M; Kageyama K; Kimura K; Eguchi S; Yamamoto A; Tanaka R; Nota T; Yonezawa H; Nishiofuku H; Sakai Y; Tani N; Jogo A; Terai M; Sato T; Ishizawa T; Miki Y
    Sci Rep; 2024 May; 14(1):10529. PubMed ID: 38719893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
    Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
    Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
    Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
    Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and application of patient-derived xenograft models in pancreatic cancer research.
    Wang CF; Shi XJ
    Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Yamashita Y; Takamori H; Kanemitsu K; Baba H
    Cardiovasc Intervent Radiol; 2007; 30(5):912-21. PubMed ID: 17710478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy.
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Takamori H; Chikamoto A; Kanemitsu K; Yamashita Y
    Cardiovasc Intervent Radiol; 2007; 30(3):383-91. PubMed ID: 17225972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
    Iwauchi T; Amano R; Ohira G; Nakamoto K; Doi Y; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2373-5. PubMed ID: 21224577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.
    Allaway RJ; Fischer DA; de Abreu FB; Gardner TB; Gordon SR; Barth RJ; Colacchio TA; Wood M; Kacsoh BZ; Bouley SJ; Cui J; Hamilton J; Choi JA; Lange JT; Peterson JD; Padmanabhan V; Tomlinson CR; Tsongalis GJ; Suriawinata AA; Greene CS; Sanchez Y; Smith KD
    Oncotarget; 2016 Mar; 7(13):17087-102. PubMed ID: 26934555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers.
    Kato Y; Tsuyuki A; Kikuchi K; Tokuyama J; Kurihara N; Kumamoto Y; Fujishiro Y; Ebinuma H
    Anticancer Res; 2005; 25(1B):477-82. PubMed ID: 15816615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study of Patient-Derived Tumor Models of Pancreatic Ductal Adenocarcinoma Involving Orthotopic Implantation.
    Yanagihara K; Iino Y; Yokozaki H; Kubo T; Oda T; Kubo T; Komatsu M; Sasaki H; Ichikawa H; Kuwata T; Seyama T; Ochiai A
    Pathobiology; 2022; 89(4):222-232. PubMed ID: 35272288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients.
    Machinaga A; Hori Y; Shimizu K; Okahara K; Yanagita E; Miyoshi M; Itoh T; Sasai K
    Pancreas; 2019; 48(10):1294-1302. PubMed ID: 31688592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.
    Park JK; Kim Y; Kim H; Jeon J; Kim TW; Park JH; Hwnag YI; Lee WJ; Kang JS
    Oncotarget; 2016 Nov; 7(46):75081-75093. PubMed ID: 27655706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Kondo M; Morimoto M; Numata K; Nozaki A; Tanaka K
    Jpn J Clin Oncol; 2011 Jan; 41(1):69-75. PubMed ID: 20688778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
    Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
    PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study.
    Furuse J; Maru Y; Yoshino M; Mera K; Sumi H; Tajiri H; Satake M; Onaya H; Ishikura S; Ogino T; Kawashima M; Ikeda H
    Hepatogastroenterology; 2001; 48(37):208-11. PubMed ID: 11268967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer].
    Homma H; Niitsu Y
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):383-9. PubMed ID: 11915727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.